Skip to main content

Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine

Cel

Novel treatment options and associated personalised, patient-tailored therapies need to be explored and developed for highly heterogeneous and chemotherapy resistant cancers, such as malignant melanoma. This can only be achieved by industry-academia collaborations in newly emerging, innovative research disciplines such as translational cancer systems biology and systems medicine. These disciplines and the associated European training needs provide the foundation for the MEL-PLEX ETN. MEL-PLEX aims to understand the network-level and multi-scale regulation of disease-relevant signalling in melanoma through a combination of quantitative biomedical and computational research approaches that go significantly beyond the current state-of-the-art. Coordinated by the RCSI Centre for Systems Medicine, MEL-PLEX will train 15 early stage researchers through a highly interdisciplinary and intersectoral research training programme. MEL-PLEX comprises 11 beneficiaries and 7 partner organisations from 11 countries, including European and international leaders in personalised melanoma therapy, melanoma systems biology and cancer systems medicine. MEL-PLEX aims to (i) achieve an unmatched depth of molecular and mechanistic disease understanding, (ii) will exploit this knowledge to develop and validate predictive models for disease progression, prognosis and responsiveness to current and novel (co-)treatment options, and (iii) will provide superior and clinically relevant tools and biomarker signatures for personalising and optimising melanoma treatment. The MEL-PLEX ETN addresses current needs in academia and the private sector for researchers that have been trained in an environment that spans across biology, medicine and mathematics, that can navigate confidently between clinical, academic and private sector research environments, and that have developed an innovative and creative mindset to progress research findings towards applications.

Zaproszenie do składania wniosków

H2020-MSCA-ITN-2014
Zobacz inne projekty w ramach tego zaproszenia

System finansowania

MSCA-ITN-ETN - European Training Networks

Koordynator

ROYAL COLLEGE OF SURGEONS IN IRELAND
Adres
Saint Stephen's Green 123
2 Dublin
Irlandia
Rodzaj działalności
Higher or Secondary Education Establishments
Wkład UE
€ 184 496,25

Uczestnicy (11)

TECHNISCHE UNIVERSITAET DRESDEN
Niemcy
Wkład UE
€ 498 432,96
Adres
Helmholtzstrasse 10
01069 Dresden
Rodzaj działalności
Higher or Secondary Education Establishments
UNIVERSITE DU LUXEMBOURG
Luksemburg
Wkład UE
€ 501 120
Adres
2 Avenue De L'universite
4365 Esch-sur-alzette
Rodzaj działalności
Higher or Secondary Education Establishments
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgia
Wkład UE
€ 501 120
Adres
Oude Markt 13
3000 Leuven
Rodzaj działalności
Higher or Secondary Education Establishments
RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG

Zakończenie uczestnictwa

Niemcy
Wkład UE
€ 55 381,44
Adres
Seminarstrasse 2
69117 Heidelberg
Rodzaj działalności
Higher or Secondary Education Establishments
ONCOMARK LIMITED
Irlandia
Wkład UE
€ 265 674,60
Adres
172 Rathgar Road Rathgar
Dublin 6 Dublin
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Irlandia
Wkład UE
€ 265 674,60
Adres
Belfield
4 Dublin
Rodzaj działalności
Higher or Secondary Education Establishments
OPTIMATA LTD
Izrael
Wkład UE
€ 260 300,52
Adres
20 Zichron Yaa'kov St.
6299920 Tel Aviv
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
KRAEFTENS BEKAEMPELSE
Dania
Wkład UE
€ 290 081,88
Adres
Strandboulevarden 49
2100 Koebenhavn
Rodzaj działalności
Research Organisations
PROTATOUANS - ETAIREIA EREYNAS VIOTECHNOLOGIAS MONOPROSOPI ETAIREIA PERIORISMENIS EYTHINIS
Greece
Wkład UE
€ 242 386,92
Adres
Odos Navarchou Votsi 3
16675 Glyfada
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITY OF STUTTGART
Niemcy
Wkład UE
€ 477 664,92
Adres
Keplerstrasse 7
70174 Stuttgart
Rodzaj działalności
Higher or Secondary Education Establishments
UNIVERSITAETSKLINIKUM AACHEN

Zakończenie uczestnictwa

Niemcy
Wkład UE
€ 41 536,08
Adres
Pauwelsstrasse 30
52074 Aachen
Rodzaj działalności
Higher or Secondary Education Establishments

Partnerzy (8)

University Berne
Szwajcaria
Adres

Berne
Rodzaj działalności
Other
Merrimack
Stany Zjednoczone
Adres

North Andover
Rodzaj działalności
Other
Apogenix
Niemcy
Adres
Im Neuenheimer Feld 584
69120 Heidelberg
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Novartis
Niemcy
Adres
Roonstrasse 25
90429 Nurnberg
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
A. Plaisant Srl.
Włochy
Adres

Roma
Rodzaj działalności
Other
Mass. General Hospital
Stany Zjednoczone
Adres

Boston
Rodzaj działalności
Other
Galderma
Francja
Adres

Chede
Rodzaj działalności
Other
THE HEBREW UNIVERSITY OF JERUSALEM
Izrael
Adres
Edmond J Safra Campus Givat Ram
91904 Jerusalem
Rodzaj działalności
Higher or Secondary Education Establishments